Watch for Creative GLP-1 Agonist Dosing

December 2025

You’ll see alternative dosing strategies with GLP-1 receptor agonists (GLP-1 RAs)...to manage side effects, reduce costs, etc.

Overall evidence is sparse. Ensure safe use if patients try it.

Microdosing uses a fraction of the approved dose in the product labeling...to try to get the same benefit with less med.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote